Insider Title Company Date Price Return Shares Value
Levy Adam D. Chief Financial Officer Acrivon Therapeutics, Inc. (ACRV) 2026-01-14 $1.70 0.0% 8,832 $14,999
Return Profit / (loss) Cost
Total 0.0% $0 $14,999